Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

Elsevier
Publish with us
AI-Generated response:

Which drug can cause green to yellow vision as a side effect?

Answer generated on June 4, 2024

The AI-generated responses are for illustration purposes only and should not be used for medical purposes.

Digoxin can cause green to yellow vision as a side effect.[1]

  • Digoxin is associated with visual disturbances including yellow vision, known as xanthopsia.

  • These visual symptoms are common in patients experiencing toxicity from the drug.

  • The disturbances may persist even after other signs of toxicity have resolved.

  • In clinical trials, about 3.3% of patients reported abnormal vision while on digoxin therapy.

  • It is crucial to monitor patients for signs of digoxin toxicity, which can include these visual changes.

Additional info

Digoxin, a cardiac glycoside used primarily for the treatment of heart failure and atrial fibrillation, has a well-documented side effect profile that includes visual disturbances such as xanthopsia, where individuals perceive a yellowish tint to their vision. This side effect is particularly associated with higher levels of digoxin in the blood, indicating toxicity. Clinicians should be vigilant about monitoring digoxin levels and patient symptoms to adjust dosages accordingly and prevent the progression of toxicity. Regular follow-ups and patient education on recognizing signs of toxicity, including changes in vision, are essential components of managing therapy with digoxin.

References

Reference 1

1.

Digoxin, Elsevier ClinicalKey Drug Monograph Content last updated: April 2, 2024

Adverse Reactions Lanoxicaps therapy can produce visual disturbances such as blurred vision or yellow vision (xanthopsia). Visual disturbances are also common in patients with lanoxicaps toxicity and may persist after other signs of toxicity have resolved. In 2 randomized, double-blind, placebo-controlled trials of 123 patients taking lanoxicaps, visual impairment (i.e., abnormal vision) was reported in 4 patients (3.3%).

Adverse Reactions Lanoxin therapy can produce visual disturbances such as blurred vision or yellow vision (xanthopsia). Visual disturbances are also common in patients with lanoxin toxicity and may persist after other signs of toxicity have resolved. In 2 randomized, double-blind, placebo-controlled trials of 123 patients taking lanoxin, visual impairment (i.e., abnormal vision) was reported in 4 patients (3.3%).

Follow up questions